“…In summary, RAS gene mutations were identified in over a third of childhood cases of AML. Although estimates for the prevalence of such mutations in adult AML has varied (Needleman et al, 1986;Bos et al, 1987;Hirai et al, 1987;Toksoz et al, 1987;Farr et al, 1988;Senn et al, 1988;Yunis et al, 1988;Bartram et al, 1989), these mutations appear to be at least as common in pediatric cases as in adult cases. This suggests that the biologic differences between the leukemic cells in adult versus pediatric AML (Fialkow, 1984;Steuber et al, 1989) cannot be readily explained on the basis of RAS gene mutations.…”